Double Swords in One: Novel Selective PI3K/110β PROTAC Degraders for the Treatment of Multidrug-Resistant Cancer by Activating ERS and Inhibiting P-gp.

Juan Cen, Ping Lu, Chenwei Wang, Jing Wu, Xiaojiao Hu, Han Zhao, Mengyu Li, Mingkai Luo,Shizhen Zhao,Xiaohui Li,Shaofeng Duan

Journal of medicinal chemistry（2025）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined